Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients.

< BACK TO ARCHIVE


2022 May


Transplant Proc


http://www.ncbi.nlm.nih.gov/pubmed/35961734?dopt=Abstract


54


4

Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients.

Authors

Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients.
Ślizień Z, Muchlado M, Kubanek A, Biedunkiewicz B, Renke M, Komorowska K, Dębska-Ślizień A, Tylicki L
Transplant Proc. 2022 May; 54(4):878-883.
PMID: 35961734.

Abstract

COVID-19 mRNA vaccines have demonstrated excellent short-term safety in phase 3 trials. However, no kidney transplant recipients (KTR) were included. The aim of the study was to assess the safety and tolerability of COVID-19 mRNA vaccines in KTR.
Read This Paper